Prescription medicine
Pindolol First approved as Visken
Pindolol (Visken) is a prescription medicine with an FDA approval on record since 1982. FDA's NDC Directory lists it from 8 generic labelers, and pharmacies paid $0.854 per pindolol 10 mg tablet in the October 7, 2026 NADAC survey.
- Generic listed
- A presentation discontinued
Check it at the source: the pindolol FDA label on DailyMed (effective March 17, 2026, Sun Pharmaceutical Industries, Inc.); the NDA 18285 record on Drugs@FDA; every pindolol label on DailyMed.
Highlights of the record
FDA label of March 17, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usagePindolol tablets are indicated in the management of hypertension.
Forms and strengths
- 5 mg
- 10 mg
Tablet.
On the market
- Earliest approval on file
- September 3, 1982 Visken, Novartis; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 14 first September 3, 1992; 5 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 8 of which 8 under generic applications, 0 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $0.854 per tablet Pindolol 10 mg tablet
- Shortage (FDA)
- None current 2 past records
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 796 through July 30, 2026
What is pindolol used for?
From the label: indications and usagePindolol tablets are indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.
Conditions named in the indications of pindolol's FDA labels, with every medicine labeled for each:
From other pindolol labelsHigh blood pressure: INDICATIONS AND USAGE Pindolol tablets are indicated in the management of hypertension.
FDA pharmacologic class: beta-Adrenergic Blocker.
Source: FDA drug label (Pindolol), Sun Pharmaceutical Industries, Inc., effective March 17, 2026 (SPL set b331a73f-bf7b-4442-8901-36d016530279), via openFDA; the full label on DailyMed
Is there a generic for pindolol (Visken)?
The FDA approved the first generic pindolol on September 3, 1992. 14 generic applications are approved; 5 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists pindolol from 8 labelers under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1982 earliest approval on file
- 1992 first generic approved
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for pindolol (Visken)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $0.854 per Pindolol 10 mg tablet, up 5% from $0.812 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Pindolol 5 mg tablet (generic)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Pindolol 10 mg tablet | Generic | $0.854 per tablet | $25.62 | +5% |
| Pindolol 5 mg tablet | Generic | $0.597 per tablet | $17.91 | +14% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
Is pindolol in shortage?
No pindolol presentation is listed as in shortage in the FDA Drug Shortage Database (read October 8, 2026); its 2 records are all marked to be discontinued, the latest updated January 30, 2026. ASHP keeps a separate shortage list, which can differ.
| Presentation | Company | Status | Updated |
|---|---|---|---|
| Pindolol, Tablet, 10 mg (NDC 57664-656-88) | Sun Pharmaceutical Industries, Inc. | To Be Discontinued | January 30, 2026 |
| Pindolol, Tablet, 5 mg (NDC 57664-655-88) | Sun Pharmaceutical Industries, Inc. | To Be Discontinued | January 30, 2026 |
Source: FDA Drug Shortage Database via openFDA, updated October 8, 2026
What does the pindolol label say about other medicines?
The pindolol label names 5 other medicines in its interaction, contraindication or warning sections. The labels of 1 other medicine name pindolol. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Dobutamine | warnings | The effects of pindolol can be reversed by administration of beta-receptor agonists such as isoproterenol, dopamine, dobutamine, or norepinephrine. |
| Epinephrine | drug interactions | Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reactions. |
| Hydralazine | drug interactions | Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions. |
| Hydrochlorothiazide | drug interactions | Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions. |
| Isoproterenol | warnings | The effects of pindolol can be reversed by administration of beta-receptor agonists such as isoproterenol, dopamine, dobutamine, or norepinephrine. |
Other labels that name pindolol
Source: FDA drug label (Pindolol), Sun Pharmaceutical Industries, Inc., effective March 17, 2026 (SPL set b331a73f-bf7b-4442-8901-36d016530279), via openFDA; the full label on DailyMed
What do FAERS reports show for pindolol?
The FDA Adverse Event Reporting System holds 796 reports that list pindolol among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 63 are coded as a death and 265 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What else is labeled for the same conditions as pindolol?
75 other medicines are given the same way (oral) and in the same FDA class as pindolol or labeled mainly for the same use (high blood pressure), the same class first. High blood pressure lists all 88 medicines labeled for it, by any route. The first 8 are below. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.
| Medicine | Shared indication | Generic labelers (oral) | Pharmacy cost | Shortage |
|---|---|---|---|---|
| Metoprolol | High blood pressure | 64 labelers | $0.085 per tablet 100 mg tablet | A presentation being discontinued |
| Propranolol | High blood pressure | 38 labelers | $0.0493 per tablet 20 mg tablet | In shortage |
| Carvedilol | High blood pressure | 41 labelers | $0.0179 per tablet 6.25 mg tablet | No current entry |
| Atenolol | High blood pressure | 35 labelers | $0.0217 per tablet 25 mg tablet | No current entry |
| Labetalol | High blood pressure | 31 labelers | $0.215 per tablet 300 mg tablet | No current entry |
| Nebivolol | High blood pressure | 23 labelers | $0.141 per tablet 10 mg tablet | A presentation being discontinued |
| Nadolol | High blood pressure | 16 labelers | $0.147 per tablet 20 mg tablet | No current entry |
| Bisoprolol | High blood pressure | 24 labelers | $0.114 per tablet 5 mg tablet | No current entry |
Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)
How does pindolol compare with medicines for the same use?
3 side-by-side pages set pindolol beside a medicine whose label shares a use: approvals, generics, pharmacy cost, warnings and supply.
What next?
- Alternatives to pindolol
- 75 medicines for the same use
- Other beta blockers
- the pharmacologic class, with prices and generics
- Pindolol side effects
- the label's list beside FAERS reports
- Pindolol shortage record
- every presentation, company and date
- Check an interaction
- what two or more labels say about each other